The latest antibiotic therapies and guidelines offer effective strategies for managing carbapenem-resistant Acinetobacter baumannii infections
Robert Dutcher, PharmD
Advertisement
Articles by Robert Dutcher, PharmD
Infectious Disease Society of America guidance defines difficult-to-treat resistant Pseudomonas aeruginosa as resistance to all first-line agents.
Dr. Dutcher is a registered pharmacist based in Punta Gorda, Fla.
Advertisement
Latest Updated Articles
IDSA Guideline Recommendations for Carbapenem-Resistant Acinetobacter BaumanniiPublished: September 18th 2025 | Updated:
- Guidelines Recommend ACE Inhibitor or ARB for Heart Failure
Published: October 1st 2007 | Updated:
- When the Patient Won't Take the Medicine
Published: February 1st 2007 | Updated:
- Medication Reconciliation Is Key
Published: December 1st 2006 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Blenrep for Treatment of Relapsed or Refractory Multiple Myeloma
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
